登录并加购,请在购物车里查看协议价、货期和发货地。
选择规格
变更视图
关于此项目
经验公式(希尔记法):
C15H23NO· HCl
化学文摘社编号:
分子量:
269.81
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
261-683-0
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
assay
≥98% (HPLC)
Quality Segment
form
powder
color
white to off-white
solubility
H2O: >10 mg/mL
originator
Wyeth
SMILES string
Cl.CCC1(CCCCN(C)C1)c2cccc(O)c2
InChI
1S/C15H23NO.ClH/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13;/h6-8,11,17H,3-5,9-10,12H2,1-2H3;1H
InChI key
MPJUSISYVXABBH-UHFFFAOYSA-N
Biochem/physiol Actions
Meptazinol entered the human pharmaceutical market as a racemic mixture in the 1980s for use as an analgesic.
Meptazinol entered the human pharmaceutical market as a racemic mixture in the 1980s for use as an analgesic. Its pharmacology is not completely understood; however, its analgesic properties are mostly due to its partial agonism at the mu1 opioid receptor. Due to its partial agonism, Meptazinol antagonizes morphine dependence in vivo. Its advantage over other opiates is its reduced capacity to cause addition and respiratory depression, also due to its intrinsic activity as a partial agonist. Meptazinol has been found to have additional activity as an acetylcholinesterase (AChE) inhibitor, particularly in its (-) enantiomeric form, which may partially explain its analgesic properties. AChE inhibitors are used to treat Alzheimer′s disease, providing additional interest in this compound.
Features and Benefits
This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Still not finding the right product?
Explore all of our products under 美普他酚 盐酸盐
警示词
Warning
危险代码
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
怎么回事?
WGK 1
闪点 (F)
Not applicable
闪点 (°C)
Not applicable
